Supernus Pharmaceuticals
SUPN
#4327
Rank
โ‚ฌ2.33 B
Marketcap
40,26ย โ‚ฌ
Share price
-2.00%
Change (1 day)
40.00%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total assets

Total assets on the balance sheet as of December 2025 : โ‚ฌ1.24 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's total assets are โ‚ฌ1.24 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Supernus Pharmaceuticals - Total assets on balance sheet (from 2009 to 2025)

Total assets by year

Year Total assets Change
2025-12-31โ‚ฌ1.23 B-5.94%
2024-12-31โ‚ฌ1.31 B13.75%
2023-12-31โ‚ฌ1.15 B-27.18%
2022-12-31โ‚ฌ1.58 B6.41%
2021-12-31โ‚ฌ1.49 B21.97%
2020-12-31โ‚ฌ1.22 B18.06%
2019-12-31โ‚ฌ1.03 B21.18%
2018-12-31โ‚ฌ0.85 B141.61%
2017-12-31โ‚ฌ0.35 B20.2%
2016-12-31โ‚ฌ0.29 B70.6%
2015-12-31โ‚ฌ0.17 B53.39%
2014-12-31โ‚ฌ0.11 B39.93%
2013-12-31โ‚ฌ80.37 M13.11%
2012-12-31โ‚ฌ71.05 M71.74%
2011-12-31โ‚ฌ41.37 M17.07%
2010-12-31โ‚ฌ35.34 M-36.63%
2009-12-31โ‚ฌ55.76 M1.08%
2008-12-31โ‚ฌ55.17 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ171.30 B 13,613.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ74.56 B 5,869.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ96.71 B 7,642.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ77.42 B 6,098.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
โ‚ฌ6.77 B 442.46%๐Ÿ‡บ๐Ÿ‡ธ USA